Diego Holanda

Phase I, sarcoma, and melanoma fellow at Princess Margaret Cancer Centre

[Diego Holanda @cdiegoholanda]

@lillian_siu Thank you for all the support!

[Diego Holanda @cdiegoholanda]

Honoured to present my first poster at #CTOS2025.
Our national real-world analysis of eribulin across 9 Canadian cancer centres provides important insights for treating pretreated soft-tissue sarcomas.
Proud to contribute to improving STS care.
#Sarcoma #Oncology

[Diego Holanda @cdiegoholanda]

@saxotomy Hi Tom, for sure. I will email you.

[Diego Holanda @cdiegoholanda]

@mauriciofribei1 Great work, my friend!

[Diego Holanda @cdiegoholanda]

@mauriciofribei1 Thank you, my friend!

[Diego Holanda @cdiegoholanda]

@herbloong Thank you!!

[Thais Megid @MegidThais]

💊 Can DFS be used as a surrogate for OS in early-stage pancreatic cancer trials?
📈 In a meta-analysis of 29 RCTs (n=6777), DFS strongly correlated with OS (R=0.70 adjuvant | R=0.90 neoadjuvant).
📍 DFS may be a reliable surrogate endpoint for OS.
https://t.co/X6NagVudhU

[Camila Braganca Xavier @CamilaBragancaX]

Paper 2/2 of our pilot prediction model to determine survival probability on #immunotherapy I would like to highlight the potential importance of the HLA-A point mutations in a neoantigen-restricted scenario (TMB-low cohort) @MDAndersonNews @pmcancercentre https://t.co/Gu7C2qBpCz

[Marathon of Hope Cancer Centres Network @marathonofhope]

Our paper on how we're uniting the cancer research and care communities in Canada to accelerate precision oncology is out in @Cancer_Cell!

Read it now 👇

[Cancer Cell @Cancer_Cell]

Online Now: The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative https://t.co/9vjT8wQWlv

[Erick F. Saldanha, MD @ESaldanhaMD]

📌Happy to share our perspective on uveal melanoma management, just out in @ESMO_Open

With this amazing team @mauriciofribei1 @IanHirsch3

🔗 https://t.co/6mdjaLy7s8

[Diego Holanda @cdiegoholanda]

@CamilaBragancaX @JIPOEditors @ANaingMD @MDAndersonNews @CarlosTorradoMD @pmcancercentre @anacveneziani @MegidThais Tks for being part of this, @CamilaBragancaX

[Camila Braganca Xavier @CamilaBragancaX]

Happy to share our review on the complexity of the TME and perspectives on targeting approaches 🎯 Thank you for the strong team work @JIPOEditors @ANaingMD, @MDAndersonNews @CarlosTorradoMD & @pmcancercentre @cdiegoholanda @anacveneziani @MegidThais | https://t.co/7rTP4OiOsV

[Elise Nassif Haddad @NassifElise]

🎬 It’s a wrap on two fantastic days of #LMS discussions and science with international colleagues!
Thanks to @NLMSF for this yearly round table.
Thanks to @GladdyLab and Albiruni Razak and the Toronto group for hosting us! Thanks to all speakers and participants!

[Diego Holanda @cdiegoholanda]

@OncJournal @MegidThais @pmcancercentre @PMResearch_UHN Congratulations @MegidThais

[Diego Holanda @cdiegoholanda]

@CamilaBragancaX @ASCO @ASCOTECAG @LatinxOncology So proud of you!

[Maria Isabel Achatz MD PhD @AchatzIsabel]

Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline https://t.co/saqUP3ctOf

All women with breast cancer < 65 should get genetic testing. devem fazer o teste genético! Hospital Sírio-Libanês: única instituição da América Latina convidada.

[Diego Holanda @cdiegoholanda]

@MegidThais @MDPIOpenAccess Congrats!!

[Diego Holanda @cdiegoholanda]

@CamilaBragancaX @myESMO @GalanteLab @pafgalante @AwniBeatriz @jardim_denis So proud of you @CamilaBragancaX!

[Camila Braganca Xavier @CamilaBragancaX]

⏰ Countdown to #ESMO23 @myESMO! Meet us on Saturday and check out our work on survival predictors among TMB-low #cancer patients treated with #immunotherapy @GalanteLab @pafgalante @cdiegoholanda @AwniBeatriz @jardim_denis